Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |